Search results
Novavax’s top shareholder Shah Capital ramps up efforts for board shakeup
WHTC 1450 Holland· 4 days ago(Reuters) - Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via Yahoo News· 4 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 20 hours agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
An adjuvant made in yeast could lower vaccine cost and boost availability
UC Berkeley NewsCenter· 2 days agoVaccines save lives, as proven during the recent pandemic, but one component of most vaccines —...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 18 hours agoOn the other hand, Novavax's vaccine is differentiated. Whereas the Moderna and Pfizer/BioNTech ...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
FOX 23 News Albany· 3 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter ...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 2 days agoFor comparison, the accepted rate of blood clots is much higher in medicines prescribed in areas of women’s health, such as the combined pill. “The key...
Novavax investor Shah Capital to vote against three directors
Reuters via Yahoo Finance· 4 days agoMay 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...